Home
Conditions
Thyroid Neoplasms

Clinical trial condition

Thyroid Neoplasms

Explore clinical trials studying Thyroid Neoplasms. Study availability and eligibility vary by location and protocol.

519 public trials 124 recruiting studies

Refine in advanced search Browse all conditions

Thyroid Neoplasms trial results

Active, Not Recruiting

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

NCT03914300

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States

View all 33 locations

View Trial Details

Active, Not Recruiting

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

NCT03196518

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

NCT04285476

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations: CHU de Toulouse Toulouse, Haute-Garonne, France

Institut régional du Cancer de Montpellier Montpellier, Hérault, France

CHU de Nîmes Nîmes, France

View Trial Details

Active, Not Recruiting

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

NCT04759911

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

University of Michigan Health Systems Ann Arbor, Michigan, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

NCT01947023

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +6 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

NCT01398085

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations: Belfast Health and Social Care Trust Belfast, United Kingdom

University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom

University Hospitals Sussex NHS Foundation Trust Brighton, United Kingdom

University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom

View all 36 locations

View Trial Details

Active, Not Recruiting

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

NCT03624751

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations: Division of Endocrinology and Metabolism in Taichung Veterans General Hospital Taichung, Taiwan

View Trial Details

Active, Not Recruiting

A Study of Optical Imaging With Light From Radiotracers in Cancer Patients

NCT03484884

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China

Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China

Hunan Cancer Hospital Changsha, Hunan, China

View all 13 locations

View Trial Details

Active, Not Recruiting

Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial

NCT07255482

Conditions: Disease, Endocrine Gland Neoplasms, Endocrine System Diseases, +11 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Thyroid Neoplasms

Thyroid Neoplasms trial results

Related conditions